VENDRAMIN, ANTONIO
VENDRAMIN, ANTONIO
Dipartimento di Oncologia ed Emato-Oncologia
Non-invasive molecular monitoring in multiple myeloma patients using cell-free tumor DNA: a pilot study
2018 G. Biancon, S. Gimondi, A. Vendramin, C. Carniti, P. Corradini
A novel in-house deep sequencing method for non-invasive disease monitoring in multiple myeloma patients
2017 C. Carniti, G. Biancon, S. Gimondi, A. Vendramin, A. Bermema, S. Rizzitano, M. Magni, N. Bolli, V. Montefusco, P. Corradini
Next-generation sequencing of a family with a high penetrance of monoclonal gammopathies for the identification of candidate risk alleles
2017 N. Bolli, M. Barcella, E. Salvi, F. D'Avila, A. Vendramin, C. De Philippis, N.C. Munshi, H. Avet Loiseau, P.J. Campbell, A. Mussetti, C. Carniti, F. Maura, C. Barlassina, P. Corradini, V. Montefusco
Circulating miRNA panel for prediction of acute graft-versus-host disease in lymphoma patients undergoing matched unrelated hematopoietic stem cell transplantation
2016 S. Gimondi, M. Dugo, A. Vendramin, A. Bermema, G. Biancon, A. Cavané, P. Corradini, C. Carniti
Disease Monitoring in Multiple Myeloma Patients Using Liquid Biopsy and Next Generation Sequencing of IGH Gene Rearrangements
2016 S. Gimondi, G. Biancon, A. Vendramin, S. Zaninelli, S. Rizzitano, S.C. Malan, A. Bermema, V. Montefusco, C. Carniti, P. Corradini
Identification of Clonal Igh Gene Rearrangements By High-Throughput Sequencing of Cell Free DNA in Multiple Myeloma Patients
2015 S. Gimondi, A. Cavanè, A. Vendramin, G. Biancon, A. Bermema, V. Montefusco, P. Corradini, C. Carniti
Pharmacologic inhibition of JAK1/JAK2 signaling reduces experimental murine acute GVHD while preserving GVT effects
2015 C. Carniti, S. Gimondi, A. Vendramin, C. Recordati, D. Confalonieri, A. Bermema, P. Corradini, J. Mariotti
A novel method for the detection of minimal residual disease in B-cell malignancies : ion semiconductor sequencing for the evaluation of Igh gene rearrangements
2014 S. Gimondi, A. Cavanè, A. Vendramin, G. Biancon, P. Corradini, C. Carniti
The Graft Monocytic Myeloid Derived Suppressor Cells Content Predicts the Risk of Acute Graft versus Host Disease after Allogeneic Transplantation of Granulocyte Colony-Stimulating Factor mobilized Peripheral Blood Stem Cells
2014 A. Vendramin, S. Gimondi, A. Bermema, P. Longoni, S. Rizzitano, P. Corradini, C. Carniti
RICOSTITUZIONE IMMUNITARIA IN PAZIENTI SOTTOPOSTI A TRAPIANTO ALLOGENICO DI CELLULE STAMINALI EMOPOIETICHE: VALUTAZIONI A LUNGO TERMINE
2012 A. Vendramin
Long term patterns of humoral and cellular response after vaccination against influenza A (H1N1) in patients with hematologic malignancies
2012 J. Mariotti, F. Spina, C. Carniti, G. Anselmi, D. Lucini, A. Vendramin, F. Pregliasco, P. Corradini
Haploidentical stem cell transplantation after a reduced-intensity conditioning regimen for the treatment of advanced hematologic malignancies : posttransplantation CD8-depleted donor lymphocyte infusions contribute to improve T-cell recovery
2009 A. Dodero, C. Carniti, A. Raganato, A. Vendramin, L. Farina, F. Spina, C. Carlo Stella, S. Di Terlizzi, M. Milanesi, P. Longoni, L. Gandola, C. Lombardo, P. Corradini
Qualitative and quantitative polymerase chain reaction monitoring of minimal residual disease in relapsed chronic lymphocytic leukemia : early assessment can predict long-term outcome after reduced intensity allogeneic transplantation
2009 L. Farina, C. Carniti, A. Dodero, A. Vendramin, A. Raganato, F. Spina, F. Patriarca, F. Narni, F. Benedetti, A. Olivieri, P. Corradini